Found: 61
Select item for more details and to access through your institution.
A call to arms of specialty societies to review the WHO International Classification of Diseases, Eleventh Revision terms appropriate for the diseases they manage: The example of the Joint Allergy Academies.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).
- Published in:
- Allergy & Asthma Proceedings, 2015, v. 36, n. 2, p. 100, doi. 10.2500/aap.2015.36.3830
- By:
- Publication type:
- Article
Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
- Published in:
- Allergy & Asthma Proceedings, 2009, v. 30, n. 6, p. 612, doi. 10.2500/aap.2009.30.3298
- By:
- Publication type:
- Article
Anti-immunoglobulin E monoclonal antibody administered with immunotherapy.
- Published in:
- Allergy & Asthma Proceedings, 2006, v. 27, p. S33
- By:
- Publication type:
- Article
Managing impairment in patients with allergic rhinitis.
- Published in:
- Allergy & Asthma Proceedings, 2006, v. 27, n. 1, p. 12
- By:
- Publication type:
- Article
Ragweed Skin Test Responsiveness Correlates with Specific Immunoglobulin E Levels.
- Published in:
- Allergy & Asthma Proceedings, 2005, v. 26, n. 2, p. 103
- By:
- Publication type:
- Article
Tolerability of Retreatment with Omalizumab, a Recombinant Humanized Monoclonal Anti-IgE Antibody, during a Second Ragweed Pollen Season in Patients with Seasonal Allergic Rhinitis.
- Published in:
- Allergy & Asthma Proceedings, 2003, v. 24, n. 5, p. 323
- By:
- Publication type:
- Article
Effect of Omalizumab on Symptoms of Seasonal Allergic Rhinitis.
- Published in:
- JAMA: Journal of the American Medical Association, 2001, v. 286, n. 23, p. 2956, doi. 10.1001/jama.286.23.2956
- By:
- Publication type:
- Article
Resumen ejecutivo de ARIA 2016: vías integradas de atención para la medicina predictiva a lo largo del ciclo de vida en Argentina.
- Published in:
- Revista Alergia de Mexico, 2017, v. 64, n. 3, p. 298, doi. 10.29262/ram.v64i3.286
- By:
- Publication type:
- Article
Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.
- Published in:
- Current Allergy & Asthma Reports, 2017, v. 17, n. 3, p. 1, doi. 10.1007/s11882-017-0687-0
- By:
- Publication type:
- Article
Immunomodulators in asthma therapy.
- Published in:
- Current Allergy & Asthma Reports, 2009, v. 9, n. 6, p. 475, doi. 10.1007/s11882-009-0070-x
- By:
- Publication type:
- Article
Immunomodulation of asthma: Where do we stand?
- Published in:
- Current Allergy & Asthma Reports, 2002, v. 2, n. 6, p. 433, doi. 10.1007/s11882-002-0078-y
- By:
- Publication type:
- Article
Asthma and Allergy: Unravelling a Tangled Relationship with a Focus on New Biomarkers and Treatment.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3881, doi. 10.3390/ijms23073881
- By:
- Publication type:
- Article
Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Role of biologics in intractable urticaria.
- Published in:
- Biologics: Targets & Therapy, 2015, v. 9, p. 25, doi. 10.2147/BTT.S63839
- By:
- Publication type:
- Article
Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2427, doi. 10.1007/s13555-024-01231-y
- By:
- Publication type:
- Article
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2573, doi. 10.1007/s13555-023-01040-9
- By:
- Publication type:
- Article
Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions.
- Published in:
- Drugs, 2016, v. 76, n. 10, p. 999, doi. 10.1007/s40265-016-0599-7
- By:
- Publication type:
- Article
Critical view of anaphylaxis epidemiology: open questions and new perspectives.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2018, v. 14, p. N.PAG, doi. 10.1186/s13223-018-0234-0
- By:
- Publication type:
- Article
Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dupilumab demonstrates greater improvement in disease activity than standard-of-care H1-antihistamines in CSU.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii12, doi. 10.1093/bjd/ljad498.015
- By:
- Publication type:
- Article
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model.
- Published in:
- Clinical & Translational Allergy, 2022, v. 12, n. 3, p. 1, doi. 10.1002/clt2.12128
- By:
- Publication type:
- Article
Incidence of anaphylaxis and accidental peanut exposure: A systematic review.
- Published in:
- Clinical & Translational Allergy, 2021, v. 11, n. 8, p. 1, doi. 10.1002/clt2.12064
- By:
- Publication type:
- Article
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization.
- Published in:
- Journal of Asthma & Allergy, 2023, v. 16, p. 249, doi. 10.2147/JAA.S385645
- By:
- Publication type:
- Article
A Pragmatic Primary Practice Approach to Using Specific IgE in Allergy Testing in Asthma Diagnosis, Management, and Referral.
- Published in:
- Journal of Asthma & Allergy, 2022, v. 15, p. 1069, doi. 10.2147/JAA.S362588
- By:
- Publication type:
- Article
ARIA 2016 yönetici özeti: Yaşam döngüsü boyunca hastalıkları öngörmeye yönelik tıp uygulamaları için bütünleştirilmiş yaklaşım yolakları.
- Published in:
- Tuberculosis & Thorax / Tuberkoloz ve Toraks, 2017, v. 65, n. 1, p. 32, doi. 10.5578/tt.52766
- By:
- Publication type:
- Article
Regulator of G-Protein Signaling 2 Repression Exacerbates Airway Hyper-Responsiveness and Remodeling in Asthma.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2015, v. 53, n. 1, p. 42, doi. 10.1165/rcmb.2014-0319OC
- By:
- Publication type:
- Article
Expression and Function of a Novel Variant of Estrogen Receptor-α36 in Murine Airways.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2011, v. 45, n. 5, p. 1084, doi. 10.1165/rcmb.2010-0268OC
- By:
- Publication type:
- Article
Cultured Lung Fibroblasts from Ovalbumin-Challenged "Asthmatic" Mice Differ Functionally from Normal.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2007, v. 37, n. 4, p. 424, doi. 10.1165/rcmb.2007-0089OC
- By:
- Publication type:
- Article
Effects of Exposure to New Car Interiors in Patients With Asthma and Allergic Rhinitis.
- Published in:
- Allergy & Rhinology, 2018, v. 9, p. 1, doi. 10.1177/2152656718800060
- By:
- Publication type:
- Article
Immune modulation for treatment of allergic disease.
- Published in:
- Immunological Reviews, 2011, v. 242, n. 1, p. 258, doi. 10.1111/j.1600-065X.2011.01034.x
- By:
- Publication type:
- Article
Guidelines for Treatment of Pediatric Asthma.
- Published in:
- 2008
- By:
- Publication type:
- Letter
An approach to managing latex allergy in the health care worker.
- Published in:
- Journal of Environmental Health, 1998, v. 61, n. 1, p. 8
- By:
- Publication type:
- Article
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Probiotic Prophylaxis of Ventilator-associated Pneumonia.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2010, v. 182, n. 8, p. 1058, doi. 10.1164/rccm.200912-1853OC
- By:
- Publication type:
- Article
Molecular Pathways and Potential Therapeutic Targets of Refractory Asthma.
- Published in:
- Biology (2079-7737), 2024, v. 13, n. 8, p. 583, doi. 10.3390/biology13080583
- By:
- Publication type:
- Article
Development of neffy , an Epinephrine Nasal Spray, for Severe Allergic Reactions.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 6, p. 811, doi. 10.3390/pharmaceutics16060811
- By:
- Publication type:
- Article
Airway relaxation mechanisms and structural basis of osthole for improving lung function in asthma.
- Published in:
- Science Signaling, 2020, v. 13, n. 659, p. 1, doi. 10.1126/scisignal.aax0273
- By:
- Publication type:
- Article
A Comparison of Methods for Assessing Hypothalamic-Pituitary-Adrenal (HPA) Axis Activity in Asthma Patients Treated with Inhaled Corticosteroids.
- Published in:
- Journal of Clinical Pharmacology, 2002, v. 42, n. 3, p. 319, doi. 10.1177/009127000204200309
- By:
- Publication type:
- Article
Targeted Molecular Therapies in Allergy and Rhinology.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy of 300 IR house dust mite immunotherapy as a function of disease activity: Tertile analysis in clinical trials.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 5, p. 329, doi. 10.1111/cea.14478
- By:
- Publication type:
- Article
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS.
- Published in:
- Clinical & Experimental Allergy, 2018, v. 48, n. 12, p. 1640, doi. 10.1111/cea.13230
- By:
- Publication type:
- Article
Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2022, p. 1, doi. 10.1177/17534666221107313
- By:
- Publication type:
- Article
Hot topics in allergen immunotherapy, 2023: Current status and future perspective.
- Published in:
- Allergy, 2024, v. 79, n. 4, p. 823, doi. 10.1111/all.15945
- By:
- Publication type:
- Article
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA<sup>2</sup>LEN consensus.
- Published in:
- Allergy, 2021, v. 76, n. 8, p. 2354, doi. 10.1111/all.14815
- By:
- Publication type:
- Article
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model.
- Published in:
- Allergy, 2021, v. 76, n. 4, p. 1041, doi. 10.1111/all.14575
- By:
- Publication type:
- Article
EAACI Biologicals Guidelines—Recommendations for severe asthma.
- Published in:
- Allergy, 2021, v. 76, n. 1, p. 14, doi. 10.1111/all.14425
- By:
- Publication type:
- Article
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma
- Published in:
- Allergy, 2020, v. 75, n. 5, p. 1023, doi. 10.1111/all.14221
- By:
- Publication type:
- Article
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma.
- Published in:
- Allergy, 2020, v. 75, n. 5, p. 1058, doi. 10.1111/all.14268
- By:
- Publication type:
- Article
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma.
- Published in:
- Allergy, 2020, v. 75, n. 5, p. 1043, doi. 10.1111/all.14235
- By:
- Publication type:
- Article